Related Experiment Video
Updated: May 29, 2026

Use of In Vivo Imaging to Screen for Morphogenesis Phenotypes in Candida albicans Mutant Strains During Active Infection in a Mammalian Host
Published on: October 12, 2022
Evolutionary dynamics of Candida albicans during in vitro evolution
Mian Huang1, Mark McClellan, Judith Berman
1Department of Chemical Engineering, Texas A&M University, College Station, TX, USA.
This study tracked the evolution of Candida albicans in the presence of fluconazole. Drug resistance mutations emerged frequently and independently, with minimal fitness loss when the drug was absent.
Area of Science:
- Microbiology
- Evolutionary Biology
- Antifungal Resistance
Background:
- Mechanisms of antifungal resistance in Candida albicans are known, but evolutionary paths to resistance are not.
- Understanding resistance evolution is crucial for effective antifungal therapy.
Purpose of the Study:
- To investigate the evolutionary dynamics of Candida albicans during the emergence of fluconazole resistance.
- To identify adaptive mutations and their fitness consequences in vitro.
Main Methods:
- Utilized the visualizing evolution in real-time (VERT) method for systematic isolation of adaptive mutants.
- Evolved Candida albicans populations in vitro, with and without fluconazole exposure.
Main Results:
- An increased frequency of adaptive events was observed in the presence of fluconazole.
- Mutations conferring increased drug resistance arose frequently and independently in different lineages.
- Most drug-resistant mutants showed no significant fitness cost in the absence of fluconazole.
Conclusions:
- Rapid antifungal resistance can emerge from pre-existing mutations in Candida albicans populations.
- Fluconazole exposure accelerates the emergence of drug resistance through frequent, independent adaptive mutations.
Related Concept Videos
Evolution of New Traits in Microbes
Candidiasis
Evolutionary Processes in Microbes
Bioreactor Controls-III
Evolution of Microbial Genome
Viral Mutations
